FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135689851> ?p ?o ?g. }

• W2135689851 endingPage "1078" @default.
• W2135689851 startingPage "1071" @default.
• W2135689851 abstract "Abstract A nonmyeloablative conditioning regimen was investigated in 47 patients with hematological malignancy receiving allogeneic progenitor cells from matched, unrelated donors. The median patient age was 44 years. The majority of patients had high-risk features, including having failed a prior transplantation (29 individuals). Twenty of the transplants were mismatched for HLA class I and/or class II alleles. Recipient conditioning consisted of 20 mg CAMPATH-1H on days −8 to −4, 30 mg/m2fludarabine on days −7 to −3, and 140 mg/m2 melphalan on day −2. Graft-versus-host disease (GVHD) prophylaxis was with cyclosporine A alone. Primary graft failure occurred in only 2 of 44 evaluable patients (4.5%). Chimerism studies in 34 patients indicated that the majority (85.3%) attained initial full donor chimerism. Only 3 patients developed grade III to IV acute GVHD, and no patients have yet developed chronic extensive GVHD. The estimated probability of nonrelapse mortality at day 100 was 14.9% (95% confidence interval [CI], 4.7%-25.1%). With a median follow-up of 344 days (range, 79-830), overall and progression-free survivals at 1 year were 75.5% (95% CI, 62.8%-88.2%) and 61.5% (95% CI, 46.1%-76.8%), respectively. In summary, a nonmyeloablative regimen incorporating in vivo CAMPATH-1H is effective in promoting durable engraftment in most patients and in reducing the risk of severe GVHD following matched unrelated donor transplantation." @default.
• W2135689851 created "2016-06-24" @default.
• W2135689851 creator A5001169309 @default.
• W2135689851 creator A5001865369 @default.
• W2135689851 creator A5003593849 @default.
• W2135689851 creator A5005708709 @default.
• W2135689851 creator A5017315111 @default.
• W2135689851 creator A5020972434 @default.
• W2135689851 creator A5021132331 @default.
• W2135689851 creator A5023740407 @default.
• W2135689851 creator A5026879347 @default.
• W2135689851 creator A5031825598 @default.
• W2135689851 creator A5041242319 @default.
• W2135689851 creator A5058361291 @default.
• W2135689851 creator A5060404528 @default.
• W2135689851 creator A5068293508 @default.
• W2135689851 creator A5069901411 @default.
• W2135689851 creator A5072971421 @default.
• W2135689851 creator A5076984999 @default.
• W2135689851 creator A5077775706 @default.
• W2135689851 creator A5078045295 @default.
• W2135689851 creator A5083961884 @default.
• W2135689851 creator A5089096852 @default.
• W2135689851 date "2002-02-01" @default.
• W2135689851 modified "2023-10-18" @default.
• W2135689851 title "Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen" @default.
• W2135689851 cites W107716097 @default.
• W2135689851 cites W1547120987 @default.
• W2135689851 cites W1683467081 @default.
• W2135689851 cites W1789478788 @default.
• W2135689851 cites W1864748840 @default.
• W2135689851 cites W1883328448 @default.
• W2135689851 cites W1951884638 @default.
• W2135689851 cites W1989053318 @default.
• W2135689851 cites W2015362105 @default.
• W2135689851 cites W2019032148 @default.
• W2135689851 cites W2019248811 @default.
• W2135689851 cites W2052498524 @default.
• W2135689851 cites W2054405406 @default.
• W2135689851 cites W2067564880 @default.
• W2135689851 cites W2075270208 @default.
• W2135689851 cites W2098425130 @default.
• W2135689851 cites W2117730045 @default.
• W2135689851 cites W2122567519 @default.
• W2135689851 cites W2147980413 @default.
• W2135689851 cites W2198037418 @default.
• W2135689851 cites W2249621957 @default.
• W2135689851 cites W2288682663 @default.
• W2135689851 cites W2408529386 @default.
• W2135689851 cites W2413215608 @default.
• W2135689851 cites W3024075650 @default.
• W2135689851 cites W4230181738 @default.
• W2135689851 cites W4246085869 @default.
• W2135689851 cites W4251178308 @default.
• W2135689851 cites W4377470768 @default.
• W2135689851 cites W44995847 @default.
• W2135689851 cites W64434556 @default.
• W2135689851 doi "https://doi.org/10.1182/blood.v99.3.1071" @default.
• W2135689851 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11807015" @default.
• W2135689851 hasPublicationYear "2002" @default.
• W2135689851 type Work @default.
• W2135689851 sameAs 2135689851 @default.
• W2135689851 citedByCount "348" @default.
• W2135689851 countsByYear W21356898512012 @default.
• W2135689851 countsByYear W21356898512013 @default.
• W2135689851 countsByYear W21356898512014 @default.
• W2135689851 countsByYear W21356898512015 @default.
• W2135689851 countsByYear W21356898512017 @default.
• W2135689851 countsByYear W21356898512018 @default.
• W2135689851 countsByYear W21356898512019 @default.
• W2135689851 countsByYear W21356898512020 @default.
• W2135689851 countsByYear W21356898512021 @default.
• W2135689851 countsByYear W21356898512023 @default.
• W2135689851 crossrefType "journal-article" @default.
• W2135689851 hasAuthorship W2135689851A5001169309 @default.
• W2135689851 hasAuthorship W2135689851A5001865369 @default.
• W2135689851 hasAuthorship W2135689851A5003593849 @default.
• W2135689851 hasAuthorship W2135689851A5005708709 @default.
• W2135689851 hasAuthorship W2135689851A5017315111 @default.
• W2135689851 hasAuthorship W2135689851A5020972434 @default.
• W2135689851 hasAuthorship W2135689851A5021132331 @default.
• W2135689851 hasAuthorship W2135689851A5023740407 @default.
• W2135689851 hasAuthorship W2135689851A5026879347 @default.
• W2135689851 hasAuthorship W2135689851A5031825598 @default.
• W2135689851 hasAuthorship W2135689851A5041242319 @default.
• W2135689851 hasAuthorship W2135689851A5058361291 @default.
• W2135689851 hasAuthorship W2135689851A5060404528 @default.
• W2135689851 hasAuthorship W2135689851A5068293508 @default.
• W2135689851 hasAuthorship W2135689851A5069901411 @default.
• W2135689851 hasAuthorship W2135689851A5072971421 @default.
• W2135689851 hasAuthorship W2135689851A5076984999 @default.
• W2135689851 hasAuthorship W2135689851A5077775706 @default.
• W2135689851 hasAuthorship W2135689851A5078045295 @default.
• W2135689851 hasAuthorship W2135689851A5083961884 @default.
• W2135689851 hasAuthorship W2135689851A5089096852 @default.
• W2135689851 hasBestOaLocation W21356898511 @default.
• W2135689851 hasConcept C126322002 @default.
• W2135689851 hasConcept C141071460 @default.

• next